Mevlüde İnanç

ORCID: 0000-0002-3737-3420 · 1 paper in corpus · active 2025

Study types

  • article 1
article 2025
The Effect of Bazedoxifene and Fulvestrant for Preventing Ovarian Hyperstimulation Syndrome: An Experimental Study
·doi:10.3390/jcm14207435

Fulvestrant and bazedoxifene may reduce OHSS severity by lowering ascites formation and weight gain. These agents could be potential therapeutic candidates for OHSS with appropriate timing and dosage.